BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22512478)

  • 21. Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action.
    Buck AC
    J Urol; 2004 Nov; 172(5 Pt 1):1792-9. PubMed ID: 15540722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
    Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
    J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botanical derivatives for the prostate.
    Cristoni A; Di Pierro F; Bombardelli E
    Fitoterapia; 2000 Aug; 71 Suppl 1():S21-8. PubMed ID: 10930709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.
    Hizli F; Uygur MC
    Int Urol Nephrol; 2007; 39(3):879-86. PubMed ID: 17203353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
    Coulson S; Rao A; Beck SL; Steels E; Gramotnev H; Vitetta L
    Complement Ther Med; 2013 Jun; 21(3):172-9. PubMed ID: 23642948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia].
    Aliaev IuG; Vinarov AZ; Demidko IuL; Spivak LG
    Urologiia; 2013; (4):32-6. PubMed ID: 24159762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.
    Prescrire Int; 2010 Aug; 19(108):181-2. PubMed ID: 20941857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study.
    Safarinejad MR
    J Herb Pharmacother; 2005; 5(4):1-11. PubMed ID: 16635963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do we really need herbal medicine in LUTS/BPH treatment in the 21
    Pinggera GM; Frauscher F
    Expert Opin Drug Saf; 2016 Dec; 15(12):1573-1575. PubMed ID: 27461908
    [No Abstract]   [Full Text] [Related]  

  • 30. Phytotherapy in the treatment of benign prostatic hyperplasia.
    Lowe FC; Fagelman E
    Curr Opin Urol; 2002 Jan; 12(1):15-8. PubMed ID: 11753128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome.
    Sökeland J
    BJU Int; 2000 Sep; 86(4):439-42. PubMed ID: 10971268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.
    Willetts KE; Clements MS; Champion S; Ehsman S; Eden JA
    BJU Int; 2003 Aug; 92(3):267-70. PubMed ID: 12887481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementary and alternative medications for benign prostatic hyperplasia.
    Keehn A; Lowe FC
    Can J Urol; 2015 Oct; 22 Suppl 1():18-23. PubMed ID: 26497340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inhibiting effects of Urtica dioica root extracts on experimentally induced prostatic hyperplasia in the mouse.
    Lichius JJ; Muth C
    Planta Med; 1997 Aug; 63(4):307-10. PubMed ID: 9270373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Phytotherapy of benign prostatic hyperplasia. Current evidence-based evaluation].
    Dreikorn K; Berges R; Pientka L; Jonas U
    Urologe A; 2002 Sep; 41(5):447-51. PubMed ID: 12426861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH).
    Quiles MT; Arbós MA; Fraga A; de Torres IM; Reventós J; Morote J
    Prostate; 2010 Jul; 70(10):1044-53. PubMed ID: 20503393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms.
    Koch E
    Planta Med; 2001 Aug; 67(6):489-500. PubMed ID: 11509966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia?
    Argirović A; Argirović D
    Vojnosanit Pregl; 2013 Dec; 70(12):1091-6. PubMed ID: 24450252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The association of Serenoa repens, lycopene and selenium is superior to Serenoa repens alone in reducing benign prostatic hyperplasia].
    Squadrito F; Morgia G
    Urologia; 2011; 78(4):297-9. PubMed ID: 21786236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
    Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
    Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.